Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa Wilson, Hannah M. Harris, Shainnel O. Eans, et al.
Drug and Alcohol Dependence (2020) Vol. 216, pp. 108310-108310
Closed Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand
Nisa Leksungnoen, Tushar Andriyas, Chatchai Ngernsaengsaruay, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 13
Phytochemical analysis of water and ethanol liquid extracts prepared using freshly harvested leaves of Mitragyna speciosa (Korth.)
Thiruventhan Karunakaran, Balasingam Vicknasingam, Marek C. Chawarski
Natural Product Research (2024), pp. 1-8
Open Access | Times Cited: 2
Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
Antonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Kratom (Mitragyna speciosa Korth.) an overlooked medicinal plant in Malaysia
Gregory Domnic, Suresh Narayanan, Nethia Mohana‐Kumaran, et al.
Journal of Substance Use (2021) Vol. 27, Iss. 1, pp. 1-6
Closed Access | Times Cited: 16
Respiratory effects of oral mitragynine and oxycodone in a rodent model
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson, et al.
Psychopharmacology (2022) Vol. 239, Iss. 12, pp. 3793-3804
Open Access | Times Cited: 12
Kratom withdrawal: Discussions and conclusions of a scientific expert forum
Jack E. Henningfield, Marek C. Chawarski, Albert Garcia‐Romeu, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100142-100142
Open Access | Times Cited: 6
Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 304-316
Closed Access | Times Cited: 6
Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States
Kevin Y. Xu, Carrie M. Mintz, Jacob T. Borodovsky, et al.
The Primary Care Companion For CNS Disorders (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 13
Adolescent kratom exposure affects cognitive behaviours and brain metabolite profiles in Sprague-Dawley rats
Aiman Nadhirah Zul Aznal, Nurul Aqmar Mohamad Nor Hazalin, Zurina Hassan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Kratom-induced acute respiratory distress syndrome (ARDS)
Justine Chinnappan, Diane Casini, Yasaman Navari, et al.
European Journal of Case Reports in Internal Medicine (2023)
Open Access | Times Cited: 4
Kratom as a potential substance use disorder harm reduction agent
MeShell Green, Nina Vadiei, Charles A. Veltri, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice
Kai Yue, Jonathan L. Katz, Xiji Shu
Psychopharmacology (2022) Vol. 239, Iss. 3, pp. 897-908
Closed Access | Times Cited: 6
Kratom: Substance of Abuse or Therapeutic Plant?
David A. Gorelick
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 3, pp. 415-430
Closed Access | Times Cited: 6
Antibacterial Activity of Juglans regia L. Dry Husk Extract against Streptococcus mutans and Lactobacillus
Ola Hameed Turki, Zainab Juma Jafar
Dental Hypotheses (2023) Vol. 14, Iss. 1, pp. 29-31
Open Access | Times Cited: 3
Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review
Alexandra Arenson, Cynthia I. Campbell, Ilan Remler
Journal of Addictive Diseases (2023) Vol. 42, Iss. 3, pp. 253-263
Closed Access | Times Cited: 3
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy
Daniel Farkas, Ziva D. Cooper, Laila N. Heydari, et al.
Cannabis and Cannabinoid Research (2023)
Closed Access | Times Cited: 3
Characterization of urinary protein profile in regular kratom ( Mitragyna speciosa korth.) users in Malaysia
Rana Khudhair Jasim, Zurina Hassan, Darshan Singh, et al.
Journal of Addictive Diseases (2021) Vol. 40, Iss. 2, pp. 235-246
Closed Access | Times Cited: 7
Kratom (<i>Mitragyna speciosa</i>) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis
Yuting Yang, Christian P. Müller, Darshan Singh
European Addiction Research (2024) Vol. 30, Iss. 4, pp. 252-274
Closed Access
Serotonin Release Mediates Analgesia via Opioidergic System and Withdrawal Symptoms in Chronic Kratom Extract-Treated Mice
Dwi Wahyu Indriani, Siti Irma Rahmawati, Asep Bayu, et al.
Research Square (Research Square) (2024)
Open Access
The neuropharmacology of kratom, a novel psychoactive natural product
MeShell Green, Charles A. Veltri, Walter C. Prozialeck, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111215-111215
Closed Access
The Safety of Multiple-Dose Liquid Blend Containing Kava and Kratom in Healthy Adults
Jaustin Dufour, Xinjie Lin, Jun Wang, et al.
Cureus (2024)
Open Access
An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference
Ariana C. Brice‐Tutt, Shainnel O. Eans, Dmitry Yakovlev, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 217, pp. 173405-173405
Open Access | Times Cited: 2
Kratom (Mitragyna speciosa)
Kirsten E. Smith, Oliver Grundmann, Marc T. Swogger, et al.
Oxford University Press eBooks (2023), pp. 386-418
Closed Access
Negative allosteric modulation of the µ-opioid receptor
Evan S. O’Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Mitragyna speciosa as a Potential Substitute Therapy in Opioid Dependence: A Case Report
Karniza Khalid, Jason S.K. Wong, Ruzita Jamaluddin
Pharmaceutical Sciences and Research (2022) Vol. 9, Iss. 1
Open Access

Scroll to top